[1] Cabral BMI,Edding SN,Portocarrero JP,et al.Rhabdomyolysis[J].Dis Mon,2020,66(8):101015.DOI:10. 1016/j. disamonth.2020.101015.
[2] 李宇,樊晖晖,冯晓俊,等.基于文献的药源性低钾血症伴发横纹肌溶解病例分析[J].药物流行病学杂志,2022,31(8):567-571.DOI:10.19960/j.cnki.issn1005-0698.2022. 08.011.
[3] Baeza-Trinidad R.Rhabdomyolysis: A syndrome to be considered[J].Med Clin (Barc),2022,158(6):277-283.DOI:10.1016/j.medcli.2021.09.025.
[4] Lane R,Phillips M.Rhabdomyolysis[J].BMJ,2003,327(7407):115-116.DOI:10.1136/bmj.327.7407.115.
[5] Rabenstein M,Abicht A,Brunn A,et al.Persistent hypokalaemia and intermittent muscle weakness[J].Pract Neurol,2022,22(6):518-520.DOI:10.1136/pn-2022- 003433.
[6] Dandörfer A,Studhalter M.An unusual case of rhabdomyolysis[J].Praxis (Bern 1994),2021,110(9):525-528.DOI:10.1024/1661-8157/a003683.
[7] 穆妮热·阿塔吾拉,郭艳英.低钾血症病因与发病机制的研究进展[J].中国医药科学,2022,12(18):39-43.DOI:10.3969/j.issn.2095-0616.2022.18.011.
[8] Baker LW,Trautman C.Refractory hypokalemia: a quiz[J].Am J Kidney Dis,2022,79(1):A15-A17.DOI:10.1053/j.ajkd. 2021.06.032.
[9] 宋晨音.厄贝沙坦氢氯噻嗪片治疗高血压对患者DBP、SBP指标水平影响分析[J].黑龙江医药,2022,35(5):1090-1092.DOI:10.14035/j.cnki.hljyy.2022.05.033.
[10] 邹雅.氢氯噻嗪联合厄贝沙坦或氨氯地平治疗原发性高血压的临床研究[D].重庆医科大学,2020.DOI:10.27674/d.cnki.gcyku.2020.001225.
[11] 陈新卫,任路平,邓志安,等.低钾血症首诊的干燥综合征致Ⅰ型肾小管酸中毒 并发甲状腺功能减退1例[J].医学理论与实践,2018,31(14):2155-2156.DOI:10.19381/j.issn. 1001-7585.2018.14.058.
[12] Sirkeci O,Sirkeci EE,Kucukciloglu Y.Severe hypokalemia and rhabdomyolysis caused by conn syndrome[J].Clin Ter,2021,172(5):407-409.DOI: 10.7417/CT.2021.2347.
[13] Pecnik P,Müller P,Vrabel S,et al.Two cases of hypokalaemic rhabdomyolysis: same but different[J].BMJ Case Rep,2018,2018:bcr2017223609.DOI:10.1136/bcr-2017-223609.
[14] Horwitz H,Woeien VA,Petersen LW,et al.Hypokalemia and rhabdomyolysis[J].J Pharmacol Pharmacother,2015,6(2):98-99.DOI:10.4103/0976-500X.155488.
[15] 陈欢,何颖雪,陈之力.横纹肌溶解并发急性肾损伤的危险因素分析[J].中国中西医结合肾病杂志,2022,23(12):1095-1097.DOI:10.3969/j.issn.1009-587X.2022.12.018.
[16] 周明雪,吴春波,赵建荣,等.横纹肌溶解致急性肾损伤的发病机制及诊治进展[J].医学综述,2022,28(3):522-526.DOI:10.3969/j.issn.1006-2084.2022.03.020.
|